• Asian Pacific Journal of Cancer Prevention
• /
• 제13권9호
• /
• pp.4357-4361
• /
• 2012

Objective: The guidelines on indications for prophylactic use of Bacille Calmette-Gu$\acute{e}$rin (BCG) against non-muscle-invasive bladder cancer (NMIBC) have changed over the years. In order to assess the impact on outcome, the present retrospective comparison of BCG efficacy by time period with Japanese patients was conducted. Patients and Methods: A total of 146 cases of NMIBC treated with BCG since February 1985 were retrospectively evaluated. All patients received 80 mg of BCG (Tokyo 172 strain) six to eight times a week for prophylactic use. Comparison was made among three historical groups (Group A: 1980's, 39 cases; Group B: 1990's, 61 cases; Group C: 2000's, 46 cases). Results: In total, recurrence was seen in 55 of the 146 cases (37.7%), and progression in 14 (9.6%), 1 patient dying of cancer. These overall results were similar to those outlined in previous reports. However, the outcomes of this time-period-based analysis indicated a tendency for a shorter time to recurrence in patients after 2000, although a log-rank test showed no significance (P=0.229). Seven of the cases featuring progression (i.e., half of all such cases) were among the 46 Group C patients (15.2%). Excluding these progressive cases, there was no significant difference among the remaining 132 patients in the three groups. Conclusion: This study results revealed a tendency for a lower non-recurrence rate after 2000 in our series. This could stem from a number of factors, including changes in BCG indication criteria and the evolution of histopathological diagnostic criteria.

• 한국어병학회지
• /
• 제10권1호
• /
• pp.45-52
• /
• 1997

단백질 결합 다당류인 PS-K가 Edwardsiella tarda의 감염에 대한 나일 틸라피아(Oreochromis niloticus)의 저항력 증강 효과에 대한 능력분석을 실시하였다. PS-K를 0.1 mg/g 어체중의 농도로 처리한 나일 틸라피아에 대하여 여러 농도외 E. tarda로 공격 실험을 하였다. 저농도($1.2{\times}10^7$ 그리고 $1.2{\times}10^8$ cfu/틸라피아)의 공격에 대하여 PS-K 처리구는 100% 생존율을 나타내었고 대조구는 각각 50%와 100%의 폐사율을 보여 주었다. 그러나 고농도의 E. tarda($1.2{\times}10^9$ 그리고 $1.2{\times}10^{10}$ cfu/틸라피아) 공격에 대해서는 약간의 수명 연장효과만 있었을뿐 대조구와 같이 100%의 폐사율을 보여 주었다. E. tarda($1.2{\times}10^7$ cfu/틸라피아) 공격 1주일 후 PS-K를 복강 투여한 나일 틸라피아는 100%의 생존율을 나타내었으나 대조구는 50% 생존율을 나타내어 PS-K가 가지고 있는 치료제로서의 잠재력을 보여 주었다. 그리고 PS-K 투여 1주일 후 주사된 E. tarda FKC에 대하여 보여준 나일 틸라피아의 높은 항체 반응은 PS-K가 어류의 특이 액성 면역반응에 관여하여 어류가 세균 감염시 높은 저항성을 갖게 하여 주는 것으로 나타났다.

• Asian Pacific Journal of Cancer Prevention
• /
• 제15권3호
• /
• pp.1233-1239
• /
• 2014

Background: The incidence of brain metastases (BM) varies in patients with non-small cell lung cancer (NSCLC), calls into question the value of prophylactic cranial irradiation (PCI). It is possible that clinicopathologic characteristics are associated with the development of BM, but these have yet to be identified in detail. Thus, we conducted the present meta-analysis on risk factors for BM and the value of PCI in patients with NSCLC. Methods: Eligible data were extracted and the risk factors for BM and the value of PCI in patients with NSCLC were analyzed by calculating the pooled odds ratio (OR). Heterogeneity was detected using Q and I-squared statistics, and publication bias was tested by funnel plots and Egger's test. Results: Six randomized controlled trials with a focus on the value of PCI and 13 eligible studies with a focus on risk factors for BM were included. PCI significantly reduced the incidence of BM in patients with NSCLC (p=0.000, pooled OR=0.34, 95% confidence interval = 0.37-0.59). Compared with non-squamous cell carcinoma, squamous cell carcinoma was associated with a low incidence of BM in patients with NSCLC (p=0.000, pooled OR=0.47, 95% confidence interval =0.34-0.65). The funnel plot and Egger's test suggested that there was no publication bias in the current meta-analysis. Conclusions: This meta-analysis provides statistical evidence that compared with non-squamous cell carcinoma, squamous cell carcinoma can be used as a predictor for BM in patients with NSCLC, and PCI might reduce the incidence of BM in patients with NSCLC, but does not provide a survival benefit.

• 한국미생물·생명공학회지
• /
• 제27권5호
• /
• pp.419-425
• /
• 1999

Prophylactic effects of Bifidobacterium longum HY8001, Korean isolate, against Escherichia coli O157:H7 and Salmonella typhimurium DT104 enteric infection were examined at four groups of specific pathogen free(SPF)-ICR mouse for each pathogen. B. longum HY8001+B. typhimurium DT104+B. longum HY8001(BL+ST+BL) group and B. longum HY8001+E. coli O157:H7+B. longum HY8001(BL+E+BL) group were fed with B. longum HY8001 before and after E. coli O157:H7 or s. typhimurium DT104 challenge, while B. longum HY8001+S. typhimurium DT104(BL+ST) and B. longum HY8001+e. coli O157:H7(BL+E) groups were fed with B. longum HY8001 only before E. coli O157:H7 or S. typhimurium DT104 challenge. E. coli O157:H7(E) and S. typhimurium DT104(ST) groups were challenged with each pathogen without B. longum HY8001 administration and control groups were administered with phosphate buffered solution(PBS). After the oral administration with B. longum HY8001(109cfu), th emice were challenged with E. coli O157:H7(2$\times$1010cfu) or S. typhimurium DT104(108cfu) and the mortality rate and the fecal shedding of challenged pathogen were also examined define the reactivity of the B. longum HY8001. Production of toxin neutralizing substance(s) of B. longum HY8001 was determined by cell cytotoxicity assay using Vero cells. Fecal shedding of th eS. typhimurium DT104 was significantly decreased in BL+ST+BL group fed with B. longum HY8--1 before and after challenge(p<0.05), while the fecal shedding s of S. typhimurium DT104 in BL+ST and St groups remained more than 106cfu. the protective effect of the B. longum HY8001 against E. coli O157:H7 was significantly high only in BL+E+BL group fed with b. longum Hy8001 before and after E. coli O157:H7 challenge from the result of fecal E. coli O157:H7 isolation rate, mortality rate, and intestinal contents culture to detect E. coli O157:H7. the mortality rate of the BL+e and E groups. The cytopathic effect (CPE) of the Vero cytotoxin (Shiga like toxin I & II) in Vero cell was neutralized in B. longum HY8001 culture supernatant added wells which indicate the presence of soluble Vero cytotxin neutralizing substance(s) in B. longum HY8001 culture suprnatant.

• 한국잠사곤충학회지
• /
• 제15권1호
• /
• pp.15-25
• /
• 1973

본인은 1972년 춘잠기와 추잠기에 걸쳐서 서울대학교농과대학 잠실에서 FZD의 누에병치료약으로서의 응용가능성을 검토한바 있다. 첫째로 FZD의 누에에의 경구적투약이 가능함을 알아낸 본인은 FZD의 4가지 누에병병원체 (Bacillus thuringiensis, Aspergillus flavus, Aspergillus oryzae, Isaria farinosa)에 대한 시험관내 항균력 측정, B.thuringiensis 로써 일으킨 실험적연화병에 대한 FZD의 발병억제효과 내지는 치료효과 관찰 등 일련의 실험을 거쳐, FZD은 실험적세균성연화병에 대해서 발병 억제효과와 치료효과를 겸해서 발휘한다는 기본적 사실을 밝혔다. 즉, 푸라졸리돈은 시험관내항균력측정에 있어서 세균성 연화병의 병원체인 Bacillus thuringiensis에 대해서는 시험관법으로써는 1$\mu\textrm{g}$/mι의 농도로써 그리고 한천평판법으로써는 $\mu\textrm{g}$/mι의 농도로써 완전한 발육억제효과를 발휘했으며, 한편 B. thuringiensis가 접종된 5령기 누에에 대해서는 잠정적인 용량인 누에 10마리당 150mg. 비율의 용량(누에체액 1ml당 약 2.2mg. 비율의 용량)에 있어서 1일 1회색 2일(2회)투여할 때 거의 완전한발병억제효과와 상당히 좋은 치료효과를 발휘했다. FZD의 임상적 응용에 따르는 용량, 투약시기, 제제형태 등의 여러가지 문제는 앞으로 세밀히 검토되어야 할 것으로 안다.

• Asian-Australasian Journal of Animal Sciences
• /
• 제24권2호
• /
• pp.285-294
• /
• 2011

The abatement of methane emission from ruminants is an important global issue due to its contribution to greenhouse gas with carbon dioxide. Methane is generated in the rumen by methanogens (archaea) that utilize metabolic hydrogen ($H_2$) to reduce carbon dioxide, and is a significant electron sink in the rumen ecosystem. Therefore, the competition for hydrogen used for methanogenesis with alternative reductions of rumen microbes should be an effective option to reduce rumen methanogenesis. Some methanogens parasitically survive on the surface of ciliate protozoa, so that defaunation or decrease in protozoa number might contribute to abate methanogenesis. The most important issue for mitigation of rumen methanogenesis with manipulators is to secure safety for animals and their products and the environment. In this respect, prophylactic effects of probiotics, prebiotics and miscellaneous compounds to mitigate rumen methanogenesis have been developed instead of antibiotics, ionophores such as monensin, and lasalocid in Japan. Nitrate suppresses rumen methanogenesis by its reducing reaction in the rumen. However, excess intake of nitrate causes intoxication due to nitrite accumulation, which induces methemoglobinemia. The nitrite accumulation is attributed to a relatively higher rate of nitrate reduction to nitrite than nitrite to ammonia via nitroxyl and hydroxylamine. The in vitro and in vivo trials have been conducted to clarify the prophylactic effects of L-cysteine, some strains of lactic acid bacteria and yeast and/or ${\beta}$1-4 galactooligosaccharide on nitrate-nitrite intoxication and methanogenesis. The administration of nitrate with ${\beta}$1-4 galacto-oligosaccharide, Candida kefyr, and Lactococcus lactis subsp. lactis were suggested to possibly control rumen methanogenesis and prevent nitrite formation in the rumen. For prebiotics, nisin which is a bacteriocin produced by Lactococcus lactis subsp. lactis has been demonstrated to abate rumen methanogenesis in the same manner as monensin. A protein resistant anti-microbe (PRA) has been isolated from Lactobacillus plantarum as a manipulator to mitigate rumen methanogenesis. Recently, hydrogen peroxide was identified as a part of the manipulating effect of PRA on rumen methanogenesis. The suppressing effects of secondary metabolites from plants such as saponin and tannin on rumen methanogenesis have been examined. Especially, yucca schidigera extract, sarsaponin (steroidal glycosides), can suppress rumen methanogenesis thereby improving protein utilization efficiency. The cashew nutshell liquid (CNSL), or cashew shell oil, which is a natural resin found in the honeycomb structure of the cashew nutshell has been found to mitigate rumen methanogenesis. In an attempt to seek manipulators in the section on methane belching from ruminants, the arrangement of an inventory of mitigation technologies available for the Clean Development Mechanism (CDM) and Joint Implementation (JI) in the Kyoto mechanism has been advancing to target ruminant livestock in Asian and Pacific regions.

• Radiation Oncology Journal
• /
• 제9권2호
• /
• pp.177-184
• /
• 1991

1984년 12월 부터 1990년 2월까지 인제대학교 의과대학 부산 백병원 치료방사선과에서 송과선 및 뇌하수체상부에 위치한 종양으로 진단받은 16명의 환자에 대하여 외부 방사선 조사를 시행하였다. 조직학적 진단은 5명에서 가능했고 나머지 11명의 환자는 조직학적 진단없이 치료를 시작하였다. 방사선조사는 전뇌-척수부위(6명), 전뇌부위(9명), 종양부위(1명)로 시행하였다. 생명표에 의거한 환자의 생존율은 $71\%$였다. 조직학적 진단이 가능했던 3명, 종양 marker정상소견을 보인 7명 그리고 beta-HCG 증가를 보인 환자들은 방사선치료에 좋은 반응을 보였으나, AFP의 증가를 보인 환자에서는 방사선치료에 대한 반응이 좋지 않았다. 척수전이는 AFP증가를 보인 2예에서 관찰되었다. : 1명은 예방적 척추조사를 받았으나, 다른 한명은 받지 않았다. 이상의 고찰을 통하여 AFP의 증가를 보이는 환자에서는 방사선치료 외에 보다 적극적인 치료가 간구되어야 하며, 이런 환자에서는 조직학적 진단 없이 방사선 치료를 시작할 수 있다. 그리고 예방적 목적으로 척수조사를 하는 것은 뇌척수액 세포검사의 양성, 뇌 척수막으로의 전이, 뇌실 침범, 조직학적으로 입증된 생식세포종일 경우에는 고려할 수 있다.

• Archives of Plastic Surgery
• /
• 제49권2호
• /
• pp.195-199
• /
• 2022

Nasolacrimal duct (NLD) damage is associated in the majority of type II and III naso-orbito-ethmoid (NOE) fractures. Our study aims to investigate the efficacy and safety of prophylactic NLD intubation in the setting of facial fractures, by comparing incidence of postoperative epiphora and wound infection. A retrospective matched control study was conducted on all patients with surgically treated facial fractures from 2008 to 2013 (n=280) (IRB ref number: DSRB 2013/01198). Patients with the following fracture types were included: NOE (n=16), frontal sinus (n=2), Le Fort II/III (n=8), and > 1 type (n=48). All patients in this study were included with the intention to treat. The study group comprised patients who were intubated, while the control group patients were not intubated. Each group had 37 patients matched for age, gender, fracture type, and injury type. A single oculoplastic surgeon skilled in lacrimal surgery performed the procedure for all intubated patients. Patients with more severe and complex facial fractures were intubated with bicanalicular Crawford stents. Postoperative epiphora and infective complications (both facial wound and dacryocystitis) were assessed at 1, 3, 6, and 12 months. There was no significant difference in incidence of either postoperative epiphora (p=0.152) or wound infection (p=0.556) comparing both groups. Reduced incidence of postoperative epiphora in the study group is statistically not significant and does not support the need for prophylactic intubation. If radiographic evidence of NLD disruption or regurgitation seen on syringing on the NLD intraoperatively is present, intubation is safe and efficacious only if performed by an expert.

• 대한치과의사협회지
• /
• 제13권3호
• /
• pp.235-238
• /
• 1975

The authors had treated a patient, 54years korean male, with malignant melanoma, egg sized, in the upper left molar region and hard palate. In the patient, radical operation was made by subtotal maxilectomy and prophylactic neck dissection. We could observe complete healing in the patient with malignant melanoma involving upper left molar region and hard palate.

• Journal of Trauma and Injury
• /
• 제26권4호
• /
• pp.312-315
• /
• 2013

Abdominal compartment syndrome is one cause of deep vein thrombosis of lower extremity. Although prophylactic dose of anticoagulation agent is safely started after 24~48 hours without the evidence of active bleeding, there may be bleeding complication related to invasive procedure which trauma victims undergo. Inferior vena cava filter should be considered in the treatment plan of this complex situation.